Multi-omics reveals branched chain amino acid signatures as prognostic factors for immunotherapy efficacy in non-small cell lung cancer

被引：0
|
作者：
Dai, L. [1 ]
Lou, N. [2 ]
Yuankai, S. [2 ]
Han, X. [3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Clin Lab Dept, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp,Med Oncol, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Clin Pharmacol Res Ctr, Dongdan Campus, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
624P
引用
收藏
页码：S1629 / S1629
页数：1
相关论文
共 50 条
  • [1] Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
    Wu, Rui
    Wei, Kunchen
    Huang, Xingshuai
    Zhou, Yinge
    Feng, Xiao
    Dong, Xin
    Tang, Hao
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [2] Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
    Zheng, Yang
    Tang, Lili
    Liu, Ziling
    BMC CANCER, 2021, 21 (01)
  • [3] Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
    Yang Zheng
    Lili Tang
    Ziling Liu
    BMC Cancer, 21
  • [4] A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer
    Ye, Qing
    Falatovich, Brianne
    Singh, Salvi
    Ivanov, Alexey V.
    Eubank, Timothy D.
    Guo, Nancy Lan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [5] Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients
    Mei, Ting
    Wang, Ting
    Zhou, Qinghua
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [6] Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
    Bourbonne, Vincent
    Geier, Margaux
    Schick, Ulrike
    Lucia, Francois
    BIOMEDICINES, 2022, 10 (06)
  • [7] Integrative analysis of multi-omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer
    Chen, Yabin
    Fang, Zhaoyuan
    Tang, Ying
    Jin, Yujuan
    Guo, Chenchen
    Hu, Liang
    Xu, Yang
    Ma, Xidong
    Gao, Jie
    Xie, Mei
    Zang, Xuelei
    Liu, Sanhong
    Chen, Haiquan
    Thomas, Roman K.
    Xue, Xinying
    Ji, Hongbin
    Chen, Luonan
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (12):
  • [8] Multi-Omics Uncovers Signatures Associated with Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer Patients
    Braune, E. -B.
    Eide, I. J. Zwicky
    Grundberg, O.
    De Petris, L.
    Brustugun, O. T.
    Ekman, S.
    Hydbring, P.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S623 - S623
  • [9] Zoledronic acid enhances the efficacy of immunotherapy in non-small cell lung cancer
    Zheng, Yue
    Wang, Pei-pei
    Fu, Yang
    Chen, Yue-yun
    Ding, Zhen-Yu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [10] Expression Pattern and Prognostic Analysis of Branched-Chain Amino Acid Catabolism-Related Genes in Non-Small Cell Lung Cancer
    Yao, Xiaojun
    Deng, Yulan
    Zhou, Jian
    Jiang, Liangshuang
    Song, Yijie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (06):
12345